A new digoxin radioimmunoassay kit with a magnetisable solid-phase antibody was assessed using a recommended evaluation scheme. The kit was found to have acceptable performance characteristics, and the results are presented in the format recommended in the evaluation scheme to maximise comparability with data from other such studies. While the evaluation protocol was found to be generally workable and valid, modifications are suggested to enhance its applicability to an immunoassay system.
McCreadyPNeillDWHesbrookLMartinD.A Survey on the Use of Kits in British Clinical Chemistry Laboratories.Diagnostic Products Working Party, ACB, 1979.
3.
NeillDWRosalkiSBWildingP.A Survey on the Use of Kits in British Clinical Chemistry Laboratories.Scientific and Technical Committee, ACB, 1973.
4.
LloydPH.Technical Bulletin No. 39: A scheme for the evaluation of diagnostic kits. Ann Clin Biochem1978; 15: 136–45.
5.
RubinMBarnettRNBayseDProvisional recommendations on the evaluation of clinical chemistry kit methods. Part 2. Guidelines for the evaluation of diagnostic kits. Clin Chim Acta1979; 95: 163F–8F.
6.
Percy-RobbIWBroughtonPMGJenningsRDA recommended scheme for the evaluation of kits in the clinical chemistry laboratory. Ann Clin Biochem1980; 17: 217–26.
7.
ChardT.An introduction to radioimmunoassay and related techniques. In: WorkTSWorkE, eds. Laboratory techniques in biochemistry and molecular biology.Amsterdam: North-Holland, 1981: 466.
8.
International Federation of Clinical Chemistry (1976). Proposals for guiding principles and recommendations on labelling of clinical laboratory materials.
9.
WoodWGWachterC.A critical appraisal of a further three new commercial digoxin radioimmunoassay kits with reference to cross-reacting substances. J Clin Chem Clin Biochem1979; 17: 77–83.
